President & CEO
Brandi Simpson is president and CEO of Navigen, and is Chair of the BioUtah board of directors. Prior to joining Navigen, she held senior positions in business development, corporate strategy, and investor relations at NPS Pharmaceuticals.
Prior to joining NPS, Brandi was director of business development at Emergen, a Utah genetics start-up. She was also a life sciences management consultant at Booz Allen & Hamilton, where she advised clients on a variety of business and strategic issues including mergers and acquisitions, post-merger integration and development of new business ventures. She began her career as an investment banking analyst at Merrill Lynch, where she worked on multiple public debt and equity financing transactions, structured financings, and mergers and acquisitions.
Brandi graduated summa cum laude from the University of Utah with an honors degree in Finance. She earned an MBA degree at Stanford University’s Graduate School of Business.